Appropriate Outcome Settings for the Effectiveness of Oral Zinc Treatment for Coronavirus Disease 2019
- PMID: 36928492
- DOI: 10.1093/cid/ciad153
Appropriate Outcome Settings for the Effectiveness of Oral Zinc Treatment for Coronavirus Disease 2019
Conflict of interest statement
Potential conflicts of interest. H. M. received research funding from Asahi Kasei Pharma Corporation; FUJIFILM Toyama Chemical Co, Ltd; Shionogi & Co Ltd; Daiichi Sankyo Co, Ltd; and Sumitomo Dainippon Pharma Co, Ltd. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.Clin Infect Dis. 2023 Jan 13;76(2):185-191. doi: 10.1093/cid/ciac807. Clin Infect Dis. 2023. PMID: 36367144 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
